EPISODE · Dec 9, 2024 · 5 MIN
Day 1 Highlights from ASH 2024: Breakthroughs in Sickle Cell Disease and ITP
from Curie: Healthcare in Focus
Day 1 of ASH 2024 brought exciting advancements in hematology. In this episode, we explore highlights from pivotal trials, including etavopivat’s impact on sickle cell disease, rilzabrutinib’s rapid platelet response in ITP, and hydroxyurea’s benefits for HbSC patients. Hosted by Matt, this podcast offers clear insights into the research shaping tomorrow’s treatments.Love what you hear? Download the Curie app for daily updates and bonus episodes tailored for oncology professionals.
NOW PLAYING
Day 1 Highlights from ASH 2024: Breakthroughs in Sickle Cell Disease and ITP
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m